USSTOCK.TODAY
Market Closed
Log in Sign up

Medtronic Receives European CE Mark for Next-Generation Pacemaker Portfolio

Medical Device Network ·

MDT Medtronic Plc
$93.03 -1.69%
View chart & analysis →
  1. 1Medtronic has received European CE certification for its Vitalis next-generation pacemaker portfolio utilizing Conduction System Pacing (CSP) technology.
  2. 2A total of five newly approved pacemaker models were included.
  3. 3Medtronic leads the market with a 58.7% share of the US pacemaker market in 2025.

So what's the key point?

Medtronic received European certification for five types of pacemakers featuring new technology. This is expected to increase Medtronic's influence as a market leader.

Source Medical Device Network · View original ↗

Related 3-line summaries

Stryker enters strategic partnership with CMR Surgical and invests approximately $400 million InvestorsHub +3 · Oct 12Medtronic Appoints Felicia Kurz as VP and General Manager of Cardiac Ablation MedTech Dive · Oct 8Inflation-Resistant Healthcare Sector: Medtronic and Eli Lilly Nasdaq +1 · Oct 7
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news